MedPath

Electronic Monitoring Combined With Weekly Feedback and Reminders

Not Applicable
Completed
Conditions
Asthma
Interventions
Behavioral: intervention group
Registration Number
NCT03277664
Lead Sponsor
Shanghai Children's Medical Center
Brief Summary

A total of 96 recruited children (aged 6 months to 3 years) with mild or moderate persistent asthma who were on regular inhaled corticosteroids (ICS) were randomly allocated to receive electronic monitoring combined with instant messaging software -based weekly feeding back adherence and reminders to keep taking the ICS (intervention group) and to receive electronic monitoring only (control group). The device-monitored adherence rates and caregiver-reported adherence rates were analyzed.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
96
Inclusion Criteria
  1. patients having mild or moderate persistent asthma
  2. 6 months-3 years
  3. taking regular inhaled steroids, with no change in their medication in the last month.
Exclusion Criteria

Participants who had severe persistent asthma or another respiratory disease or did not live in Shanghai were excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
intervention groupintervention groupAll the device-monitored adherence data from the previous week were downloaded from the background database and calculated by a qualified asthma nurse. Through free IMS (WeChat; Tencent, Shenzhen, CHN) available on mobile, the nurse offered feedback to the caregivers weekly according to the adherence rate and reminded them to keep taking the ICS. Caregivers were asked monthly "Has our child inhaled the medicine according to the doctor's instructions?" and "How about the frequency?" by telephone.
Primary Outcome Measures
NameTimeMethod
device monitored adherence rateup to 6 months

The primary outcome of the study was change in the adherence rate monitored by the electronic device for 6 consecutive months. This adherence rate was calculated as the number of device recorded times /number of total times prescribed × 100%.

Secondary Outcome Measures
NameTimeMethod
caregiver-reported adherence rateup to 6 months

The secondary outcomes for the study were the caregiver-reported adherence rate and the difference between device-monitored and caregiver-reported adherence rates for 6 consecutive months. The caregiver-reported adherence rate was recorded on a monthly basis. It was offered by the caregivers of patients through answering the questions "Has our child inhaled the medicine according to the doctor's instructions" and "How about the frequency". The device-monitored and caregiver-reported adherence rates were compared monthly.

Trial Locations

Locations (1)

Shanghai children's medical center

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath